Annals of Nuclear Medicine

, Volume 23, Issue 1, pp 49–57 | Cite as

Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer

  • Motohiro Sato
  • Toshiyuki Okumura
  • Keiko Kaito
  • Moriyuki Kiyoshima
  • Yuji Asato
  • Keiko Uchiumi
  • Hiroaki Iijima
  • Ikuta Hashimoto
  • Takayuki Kaburagi
  • Ryuta Amemiya
Original Article

Abstract

Objective

The objective of this study was to assess the ability to detect pancreatic metastasis of lung cancer and to clarify the degree of fluorodeoxyglucose (FDG) accumulation and computed tomography (CT) characteristics of pancreatic metastasis from lung cancer.

Methods

A total of 573 patients (415 men and 158 women) with lung cancer were retrospectively evaluated. All patients underwent FDG-positron emission tomography (PET)/CT with contrast-enhanced CT for first=stage (313 patients; initial study group) or follow-up study (260 patients; follow-up study group). A lesion was regarded as positive for metastasis on the basis of visual judgment of the degree of increased metabolism by two experienced and independent interpreters, supported by semiquantitative evaluation on the basis of calculation of the maximum standardized uptake value (SUVmax).

Results

Abnormal accumulations in the pancreas were detected in 5 of 313 patients (1.60%) in the initial study group, and 6 of 260 patients (2.31%) in the follow-up study group. Seven of these patients had adenocarcinoma, three had small cell carcinoma, and the rest had large cell endocrine carcinoma. Tumor sizes (longitudinal diameter), measured by CT, of these 11 patients ranged from 6 mm to 52 mm (mean ± SD 8.3 mm ± 11.9 mm), and SUVmax for 1 h ranged from 3.37 to 11.1 (mean ± SD 6.12 ± 2.43). Three of these pancreatic lesions were difficult to determine by routine transaxial images, and detection was obvious only by thin-slice images or multiplanar reconstruction images. Contrast-enhanced CT showed gradual fill-in from the peripheral portion to the center. In addition, 10 of 11 cases did not show main pancreatic duct dilatation even if the tumor size was large.

Conclusions

Metastases to the pancreas in lung cancer patients are not so rare and radiologists first have an important role to detect the pancreatic mass and then suggest to metastasis as the likely diagnosis. For this purpose, FDG-PET/CT has an advantage in depicting unsuspected pancreatic metastasis from lung cancer, particularly that which is not detected by CT alone.

Keywords

FDG PET/CT Lung cancer Pancreas Metastasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rumancik WM, Megihow AJ, Bosniak MA, Hilton S. Metastatic disease to the pancreas: evaluation by computed tomography. J Comput Assist Tomogr 1984;8:829–834.PubMedCrossRefGoogle Scholar
  2. 2.
    Klein KA, Stephens DH, Welch TJ. CT characteristics of metastatic disease of the pancreas. Radiographics 1998;18:369–378.PubMedGoogle Scholar
  3. 3.
    Ferrozzi F, Bova D, Campodonico F, Chiara FD, Passari A, Bassi P. Pancreatic metastasis: CT assessment. Eur Radiol 1997;7:241–245.PubMedCrossRefGoogle Scholar
  4. 4.
    Scatarige JC, Horton KM, Sheth S, Fishman EK. Pancreatic parenchymal metastases: observations on helical CT. AJR Am J Roentgenol 2001;176:695–699.PubMedGoogle Scholar
  5. 5.
    Merkle EM, Boaz T, Kolokythas O, Haaga JR, Lewin JS, Brambs HJ. Metastases to the pancreas. Br J Radiol 1998;71:1208–1214.PubMedGoogle Scholar
  6. 6.
    Maeno T, Satoh H, Ishikawa H, Yamashita YT, Naito T, Fujiwara M, et al. Patterns of pancreatic metastasis from lung cancer. Anticancer Res 1998;18:2881–2884.PubMedGoogle Scholar
  7. 7.
    García Viadl C, Carrillo E, Barreiro B. Solitary metastasis to the pancreas in a patient with lung cancer. Arch Bronconerumol 2003;39:601.CrossRefGoogle Scholar
  8. 8.
    Liratzopoulos N, Efremidou EI, Papageorgiou MS, Romanidis K, Minopoulos GGJ, Manolas J. Extrahepatic biliary obstruction due to a solitary pancreatic metastasis of squamous cell lung carcinoma: case report. J Gastrointest Liver Dis 2006;15:73–75.Google Scholar
  9. 9.
    Johnson DH, Hainsworth JD, Greco FA. Extrahepatic biliary obstruction caused by small-cell lung cancer. Ann Intern Med 1985;102:487–490.PubMedGoogle Scholar
  10. 10.
    Chowhan NM, Madajewicz S. Management of metastasesinduced acute pancreatitis in small cell carcinoma of the lung. Cancer 1990;65:1445–1448.PubMedCrossRefGoogle Scholar
  11. 11.
    Kim KH, Kim CD, Lee SJ, Lee G, Jean YT, Lee SC, et al. Metastasis-induced acute pancreatitis in a patient with small cell carcinoma of the lung. J Korean Med Sci 1999;14:107–109.PubMedGoogle Scholar
  12. 12.
    Lowe J, Naunheim S. Current role of positron emission tomography in thoracic oncology. Thorax 1998;53:703–712.PubMedGoogle Scholar
  13. 13.
    Gambihir S, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME. A tabulated summary to the FDG PET literature. J Nucl Med 2001;42:1S–71S.Google Scholar
  14. 14.
    Towensend DW, Camey IPJ, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med; 45:4S–14S.Google Scholar
  15. 15.
    Schoder H, Gonen M. Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med 2007;48:4S–18S.PubMedCrossRefGoogle Scholar
  16. 16.
    Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography. New Engl J Med 2003;348:2500–2507.PubMedCrossRefGoogle Scholar
  17. 17.
    Antoch C, Stattaus J, Nemat AT, Mamitz AT, Beyer T, Kuehl H, et al. Non small cell lung cancer dual-modality PET/CT in preoperative staging. Radiology 2003;229:526–533.PubMedCrossRefGoogle Scholar
  18. 18.
    Shim SS, Lee LS, Kim BT, Chung MJ, Lee EJ, Han J, et al. Non small cell lung cancer preoperative comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005;236:1101–1109.CrossRefGoogle Scholar
  19. 19.
    Seki M, Tsuchita E, Hori M, Nakagawa K, Ohta H, Ueno M, et al. Pancreatic metastasis from a lung cancer. Int J Pancreatol 1998;24:55–59.PubMedGoogle Scholar
  20. 20.
    Muranaka T, Teshima K, Honda H, Nanjo T, Hanada K, Oshiumi Y. Computed tomography and histologic appearance of pancreatic metastases from distant source. Acta Radiol 1989;30:615–619.PubMedCrossRefGoogle Scholar
  21. 21.
    Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET): usefulness and limitations in “clinical reality”. Ann Nucl Med 2003;17:261–279.PubMedCrossRefGoogle Scholar
  22. 22.
    Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Itoh K, Iimura M, et al. Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography; comparison with other modalities. Clin Nucl Med 2002;25:115–119.CrossRefGoogle Scholar
  23. 23.
    Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, et al. FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med 2000;27:1835–1838.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Nuclear Medicine 2009

Authors and Affiliations

  • Motohiro Sato
    • 1
  • Toshiyuki Okumura
    • 1
  • Keiko Kaito
    • 1
  • Moriyuki Kiyoshima
    • 2
  • Yuji Asato
    • 2
  • Keiko Uchiumi
    • 3
  • Hiroaki Iijima
    • 3
  • Ikuta Hashimoto
    • 3
  • Takayuki Kaburagi
    • 3
  • Ryuta Amemiya
    • 2
  1. 1.Department of RadiologyIbaraki Prefectural Central HospitalIbarakiJapan
  2. 2.Department of SurgeryIbaraki Prefectural Central HospitalIbarakiJapan
  3. 3.Department of Internal MedicineIbaraki Prefectural Central HospitalIbarakiJapan

Personalised recommendations